FEATURED ARTICLES

• Is Double Programming Really Required For Validation?

  Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

• Why We Need Technology Consolidation In Clinical Trials

  As more and more trial designs incorporate technologies that generate an immense amount of data, data managers struggle to continuously interconnect disparate systems and standardize data. All of this fuels the need for technology consolidation.

• My Opinion: CRCs, CRAs, and CTMs Have It Tough

  With 20+ years as a CRC, CRA, clinical trial manager, and project manager, Tiffany Ashton, MAS, CCRA talks about how difficult it can be working in some of these roles in today’s clinical trials industry. 

WHITE PAPERS AND CASE STUDIES

• Master Protocols: Implementing Effective Treatment Adaptations

  From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions with minimal disruption.

• Unique IRT Implementation Considerations For Personalized Medicine Trials

  The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.

• How We Used Intelligent Automation to Transform Vendor Selection

  Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.

• Reframing Clinical Vendor Selection
• The Evolution Of Technology For Safety Notifications
• Flexible Integrations To Reduce Risks And Increase Efficiencies